Jimmy C - agree with you.
"Uncertainty" - the thing that the stock market does not like is here with TOX.
I was hopeful that the half year was delayed as they were going to announce an acquisition - and if a placement was required then to an institution and not retail investors as I see the insto ownership levels being fairl low as a weakness.
But nope - just a repeat of what was stated with some downside on the $400K number.
The market expected eps of 0.4 and they delivered 0.3.
For the full year the expectation was for 0.8 so they need 0.5 in the second half to meet this.
I would say they stumbled at the first test in this half year - but will hold for now. Seen this happen before on turnarounds and things then accelerate. All good fun - but really they should clear up the uncertainty.
Add to My Watchlist
What is My Watchlist?